Close X
Thursday, November 14, 2024
ADVT 
National

WHO may reject sole Canadian-made COVID-19 vaccine

Darpan News Desk The Canadian Press, 17 Mar, 2022 09:51 AM
  • WHO may reject sole Canadian-made COVID-19 vaccine

OTTAWA - The World Health Organization says it expects to reject the COVID-19 vaccine candidate from Canada's Medicago because of the company's ties to big tobacco.

The two-dose Medicago Covifenz vaccine was authorized in Canada last month for adults between 18 and 64 years old.

Medicago also applied for an emergency use licence through the World Health Organization, which would allow it to seek contracts for sale in a number of other countries as well as to the COVAX vaccine sharing alliance.

But Dr. Mariângela Simão, WHO's assistant director general for drug access, vaccines and pharmaceuticals, said Wednesday the WHO has strict policies about engaging with tobacco companies and arms manufacturers.

Medicago is a Quebec-based company that is partially owned by tobacco maker Philip Morris International.

"So the process is put on hold," Simão said at a WHO media briefing. "It's very likely that it won't be accepted for the emergency use licence."

Medicago President Takashi Nagao said in a written statement that Medicago has not had an "official communication" from the WHO.

"It is our understanding that this decision is linked to Medicago’s minority shareholder and not the demonstrated safety and efficacy profile of our COVID-19 vaccine," he said.

Medicago says its vaccine is the first plant-based vaccine approved in the world. It uses virus-like particles grown in a plant that is a relative of the tobacco plant. It also uses an adjuvant made by GlaxoSmithKline.

Health Minister Jean-Yves Duclos said Thursday he and Innovation Minister François-Philippe Champagne are following the process with WHO very closely.

"Minister Champagne and I have contacted Medicago to make sure that its contact with WHO is done properly," he said.

Canada invested $173-million in Medicago in 2020 to support development of the Covifenz vaccine and help Medicago expand its production facility in Quebec. It also signed a contract to buy at least 20 million doses, with options for 56 million more.

Takashi confirmed Canada is currently Medicago's first and only customer, but he said there are ongoing discussions with others. Medicago has not said if it applied for approval anywhere else yet.

"We cannot comment further on these discussions as they are confidential," he said.

Medicago is one of seven COVID-19 vaccines Canada has contracts to buy, six of which have now been approved.

But Canada is almost solely relying on the mRNA vaccines from Pfizer-BioNTech and Moderna for its vaccination program, including for boosters and children.

On Thursday, Health Canada approved the use of Moderna's COVID-19 vaccine for children between the ages of six and 11 years old.

The vaccine known as Spikevax had already been approved for those ages 12 and up. The pediatric version for children six to 11 is two 50-microgram doses. The vaccine for ages 12 and up is two 100-microgram doses.

Canada had planned to donate any excess doses to low-income countries through COVAX.

COVAX can only use vaccines issued an emergency use licence by the WHO, so a rejection of Medicago could limit where in the world the vaccine can be used.

MORE National ARTICLES

B.C. COVID-19 hospitalizations drop to 368

B.C. COVID-19 hospitalizations drop to 368
The Health Ministry said in a news release Friday the number of COVID-19 hospitalizations has dropped to 368 from 388 Thursday, with 46 people in intensive care.

B.C. COVID-19 hospitalizations drop to 368

One killed in North Vancouver shooting: RCMP

One killed in North Vancouver shooting: RCMP
Mounties say the shooting took place Friday afternoon outside the Real Canadian Superstore on Seymour Boulevard, just north of the entrance to the Iron Workers Memorial Bridge.

One killed in North Vancouver shooting: RCMP

Pandemic anniversary reminder to be vigilant

Pandemic anniversary reminder to be vigilant
This time, the deputy chief public health officer and his chief, Dr. Theresa Tam, were there to inform Canadians of the first case of the novel coronavirus in Canada.

Pandemic anniversary reminder to be vigilant

Conservative leadership race: who's in, who's out

Conservative leadership race: who's in, who's out
With Sept. 10 picked as the date for when the Conservative Party of Canada will have a new leader, time is ticking for prospective candidates and their teams to get into place. Those running have until April 19 to throw their hat into the ring and until June 3 to sell memberships.

Conservative leadership race: who's in, who's out

Businesses hurt by convoy can apply for $10K: feds

Businesses hurt by convoy can apply for $10K: feds
Fortier says small businesses have shown incredible resilience throughout the pandemic, but especially during the three weeks that anti-vaccine mandate protesters occupied the city's core.

Businesses hurt by convoy can apply for $10K: feds

Canada, India to relaunch CEPA trade talks: Ng

Canada, India to relaunch CEPA trade talks: Ng
Following meetings in New Delhi with her Indian counterpart, Shri Piyush Goyal, Ng says the two countries will pursue an "early progress" agreement as an initial step.

Canada, India to relaunch CEPA trade talks: Ng